257 related articles for article (PubMed ID: 23389882)
1. Effective antimicrobial activity of Cbf-K16 and Cbf-A7 A13 against NDM-1-carrying Escherichia coli by DNA binding after penetrating the cytoplasmic membrane in vitro.
Hao Q; Wang H; Wang J; Dou J; Zhang M; Zhou W; Zhou C
J Pept Sci; 2013 Mar; 19(3):173-80. PubMed ID: 23389882
[TBL] [Abstract][Full Text] [Related]
2. Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli.
Docobo-Pérez F; Nordmann P; Domínguez-Herrera J; López-Rojas R; Smani Y; Poirel L; Pachón J
Int J Antimicrob Agents; 2012 Mar; 39(3):251-4. PubMed ID: 22154856
[TBL] [Abstract][Full Text] [Related]
3. The antibacterial activity of BF-30 in vitro and in infected burned rats is through interference with cytoplasmic membrane integrity.
Zhou H; Dou J; Wang J; Chen L; Wang H; Zhou W; Li Y; Zhou C
Peptides; 2011 Jun; 32(6):1131-8. PubMed ID: 21515321
[TBL] [Abstract][Full Text] [Related]
4. Effective antimicrobial activity of Cbf-14, derived from a cathelin-like domain, against penicillin-resistant bacteria.
Ma L; Wang Y; Wang M; Tian Y; Kang W; Liu H; Wang H; Dou J; Zhou C
Biomaterials; 2016 May; 87():32-45. PubMed ID: 26897538
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of a snake cathelicidin-related peptide, BF-15.
Chen W; Yang B; Zhou H; Sun L; Dou J; Qian H; Huang W; Mei Y; Han J
Peptides; 2011 Dec; 32(12):2497-503. PubMed ID: 22008732
[TBL] [Abstract][Full Text] [Related]
6. Transmission of imipenem resistance determinants during the course of an outbreak of NDM-1 Escherichia coli in a sick newborn care unit.
Roy S; Singh AK; Viswanathan R; Nandy RK; Basu S
J Antimicrob Chemother; 2011 Dec; 66(12):2773-80. PubMed ID: 21930573
[TBL] [Abstract][Full Text] [Related]
7. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
Xiong Z; Zhu D; Zhang Y; Wang F
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
[TBL] [Abstract][Full Text] [Related]
8. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Cha R
Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
[TBL] [Abstract][Full Text] [Related]
10. Development of TaqMan real-time polymerase chain reaction for the detection of the newly emerging form of carbapenem resistance gene in clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii.
Manchanda V; Rai S; Gupta S; Rautela RS; Chopra R; Rawat DS; Verma N; Singh NP; Kaur IR; Bhalla P
Indian J Med Microbiol; 2011; 29(3):249-53. PubMed ID: 21860104
[TBL] [Abstract][Full Text] [Related]
11. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
[TBL] [Abstract][Full Text] [Related]
12. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
Zhanel GG; Baudry PJ; Tailor F; Cox L; Hoban DJ; Karlowsky JA
J Antimicrob Chemother; 2009 Oct; 64(4):824-8. PubMed ID: 19643776
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany.
Wienke M; Pfeifer Y; Weissgerber P; Marschal M; Autenrieth IB; Gröbner S
Chemotherapy; 2012; 58(3):241-8. PubMed ID: 22832033
[TBL] [Abstract][Full Text] [Related]
14. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
Palasubramaniam S; Muniandy S; Navaratnam P
J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
[TBL] [Abstract][Full Text] [Related]
15. Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis.
Stone NR; Woodford N; Livermore DM; Howard J; Pike R; Mushtaq S; Perry C; Hopkins S
J Antimicrob Chemother; 2011 Nov; 66(11):2677-8. PubMed ID: 21846669
[No Abstract] [Full Text] [Related]
16. Identification of New Delhi metallo-β-lactamase gene (NDM-1) from a clinical isolate of Acinetobacter junii in China.
Zhou Z; Guan R; Yang Y; Chen L; Fu J; Deng Q; Xie Y; Huang Y; Wang J; Wang D; Liao C; Gong S; Xia H
Can J Microbiol; 2012 Jan; 58(1):112-5. PubMed ID: 22181044
[TBL] [Abstract][Full Text] [Related]
17. Diversity of naturally occurring Ambler class B metallo-β-lactamases in Erythrobacter spp.
Girlich D; Poirel L; Nordmann P
J Antimicrob Chemother; 2012 Nov; 67(11):2661-4. PubMed ID: 22850693
[TBL] [Abstract][Full Text] [Related]
18. Characterization of purified New Delhi metallo-β-lactamase-1.
Thomas PW; Zheng M; Wu S; Guo H; Liu D; Xu D; Fast W
Biochemistry; 2011 Nov; 50(46):10102-13. PubMed ID: 22029287
[TBL] [Abstract][Full Text] [Related]
19. Identification and molecular characterisation of New Delhi metallo-β-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals.
Williamson DA; Sidjabat HE; Freeman JT; Roberts SA; Silvey A; Woodhouse R; Mowat E; Dyet K; Paterson DL; Blackmore T; Burns A; Heffernan H
Int J Antimicrob Agents; 2012 Jun; 39(6):529-33. PubMed ID: 22526013
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae.
Berçot B; Poirel L; Dortet L; Nordmann P
J Antimicrob Chemother; 2011 Oct; 66(10):2295-7. PubMed ID: 21807739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
